Robert-Bosch-Krankenhaus

Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study (2022) Middeke JM, Metzeler KH, Rollig C, Kramer M, Eckardt JN, Stasik S, Greif PA, et al. Journal article S3-Leitlinie: Diagnostik und Therapie biliärer Karzinome (2022) Bitzer M, Voesch S, Albert J, Bartenstein P, Bechstein W, Blödt S, Brunner T, et al. Journal article S3 Guideline - Diagnosis and treatment of biliary carcinomas: Long version 2.0 - June 2021 - AWMF Register No.: 032-053OL S3-Leitlinie - Diagnostik und Therapie biliärer Karzinome (2022) Bitzer M, Voesch S, Albert J, Bartenstein P, Bechstein W, Blödt S, Brunner T, et al. Journal article Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes (2022) Mavaddat N, Dorling L, Carvalho S, Allen J, Gonzalez-Neira A, Keeman R, Bolla MK, et al. Journal article Rare germline copy number variants (CNVs) and breast cancer risk (2022) Dennis J, Tyrer JP, Walker LC, Michailidou K, Dorling L, Bolla MK, Wang Q, et al. Journal article CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome (2022) Taube F, Georgi JA, Kramer M, Stasik S, Middeke JM, Röllig C, Krug U, et al. Journal article Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry (2022) Hanoun M, Ruhnke L, Kramer M, Hanoun C, Schaefer-Eckart K, Steffen B, Sauer T, et al. Journal article Exercise Reduces the Number of Overall and Major Osteoporotic Fractures in Adults. Does Supervision Make a Difference? Systematic Review and Meta-Analysis (2022) Hoffmann I, Shojaa M, Kohl M, von Stengel S, Becker C, Gosch M, Jakob F, et al. Journal article Mobility endpoints in marketing authorisation of drugs: What gets the European medicines agency moving? (2022) Jaeger SU, Wohlrab M, Schöne D, Tremmel R, Chambers M, Leocani L, Corriol-Rohou S, et al. Journal article, Review article S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms – Kurzversion 2.00 – Juni 2021, AWMF-Registernummer: 032-053OL (2022) Sabrina V, Michael B, Joerg A, Peter B, Wolf B, Susanne B, Thomas B, et al. Journal article